JPRN-UMIN000039686
Completed
未知
ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease - ECMOCARD Study
Critical Care Research Group The Prince Charles Hospital0 sites20,000 target enrollmentMarch 6, 2020
ConditionsCOVID-19
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Critical Care Research Group The Prince Charles Hospital
- Enrollment
- 20000
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients treated with mechanical ventilation for other concomitant causes 2\.Patients treated with ECMO for other concomitant causes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Pilot study investigating how Extracorporeal Membrane Oxygenation (ECMO) affects the major breathing muscles.Diaphragm atrophyECMOMusculoskeletal - Other muscular and skeletal disordersRespiratory - Other respiratory disorders / diseasesACTRN12616000944437Trent Donnelly20
Completed
Not Applicable
Extracorporeal membrane oxygenation in patients with coronavirus disease 2019PCR-proven COVID-19, resulting in respiratory or cardiorespiratory insufficiency, refractory to conventional therapies.NL-OMON27273/A200
Recruiting
Not Applicable
nderstanding Extracorporal Membrane Oxygenation Induced Coaguloapathy – A Prospective Cohort Study in the Intensive Care Unit (EXTRICATE)In VV-ECMO patients with severe ARDSin VA-ECMO patients with cardiac arrest during ongoing resuscitation.DRKS00033769niversität Witten/Herdecke & Klinik Köln Merheim50
Completed
Not Applicable
Extracorporeal membrane oxygenation in adults: a retrospective analysis of differences in indication, morbidity and mortality in a single-centre observational study.Extracorporal membrane oxygenationR57.0R57.2J80Cardiogenic shockSeptic shockAdult respiratory distress syndromeDRKS00014629Asklepios Klinik Langen131
Not yet recruiting
Not Applicable
itric Oxide on ExtraCorporeal Membrane Oxygenation – a randomised Trial in neonates and children (NECTAR trial).Cardiovascular failure requiring Extracorporeal Membrane OxygenationRespiratory failure requiring Extracorporeal Membrane OxygenationRespiratory - Other respiratory disorders / diseasesCardiovascular - Other cardiovascular diseasesACTRN12619001518156The University of Queensland50